ClearanceBrief
Recall Z-0282-2019 ยท FOZ Catheter, Intravascular, Therapeutic, Short-Term Less Than 30 Days

Arrow International Inc

Arrow AGB + Multi-Lumen CVC Kit, Cat. No. CDC-42703-B1A. Product Usage - The Arrow CVC is intended to provide short-term (< 30 days) central venous access for treatment of diseases or conditions requiring central venous access, including, but not limited to the following: Lack of usable peripheral IV sites, Central venous pressure monitoring, Total parenteral nutrition (TPN), Infusions of fluids,

DateAug 30, 2018
StatusTerminated
ReasonThe product was shipped after its expiry date due to a system error. The product lidstock identifies the correct expiration date however the accompanying purchase order shipping documentation identifies an incorrect expiration date. Per standard clinical practice the lidstock would most likely be checked prior to use and the product would not be used leading to a minor delay while a replacement is located. In the unlikely event that the product lidstock is not checked prior to use, there is potential for use of expired product, and product functionality/or sterility cannot be guaranteed.
Root causeUnder Investigation by firm
ActionOn August 29, 2018, the firm notified customers via an Urgent Medical Device Recall letter. The letter informed customers of the product issue. Customers were advised to do the following: 1. If you have affected stock, immediately discontinue use and quarantine any products with the product code and lot number listed above, so that the affected products can be returned to Arrow. 2. To return product, complete the enclosed Recall Acknowledgement Form and fax it to 1-855-419-8507, Attn: Customer Service or email to recalls@teleflex.com. This will allow us to document the amount of product you
Quantity105
DistributionUS nationwide in the states of CA, FL, NC, and RI.
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K993691ARROWG +ARD BLUE PLUS ANTIMICROBIAL MULTI-LUMEN CENTRAL VENOUS CATHETER
Arrow Intl., Inc., Mar 8, 2000